P/E at 66.01 vs Industry's 69.48: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Slight Discount in a High-P/E Industry

Apollo Hospitals Enterprise Ltd. trades at a P/E of 66.01, marginally below the hospital industry’s average of 69.48. This valuation suggests that while the stock commands a premium relative to many sectors, it is slightly more attractively priced than its direct peers. The hospital sector is known for elevated valuations due to steady demand and growth prospects, but Apollo Hospitals’s discount could reflect investor caution or a subtle reassessment of growth expectations. The market cap stands at a robust ₹1,28,931.70 crores, underscoring its large-cap stature within the healthcare space.

Performance Across Timeframes: Strong Long-Term Gains Amid Short-Term Fluctuations

The stock’s performance over the past year has been impressive, delivering a 26.59% gain compared to the Sensex’s 1.55% loss. This outperformance extends over longer horizons as well, with three-year returns at 82.23%, five-year returns at 120.54%, and a remarkable ten-year gain of 550.54%, all substantially exceeding the Sensex’s respective returns of 19.69%, 44.11%, and 183.06%. These figures highlight Apollo Hospitals’s consistent value creation over time.

However, the short-term momentum shows some moderation. The three-month return of 10.77% is positive but less pronounced relative to the one-year figure, and the stock underperformed the sector by 1.04% on the latest trading day, closing at ₹8,906.75. The one-month and one-week returns of 1.42% and 1.67% respectively are roughly in line with the Sensex, indicating a period of consolidation or cautious trading. This divergence between strong long-term performance and more muted recent gains raises the question of whether the current momentum is sustainable — is this a temporary pause or a sign of shifting market sentiment?

Moving Average Configuration: Bullish Across All Key Averages

Technically, Apollo Hospitals is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This comprehensive positioning above both short and long-term averages signals a strong upward trend and suggests that the stock is in a sustained recovery or continuation phase rather than a breakdown or dead-cat bounce. The proximity to its 52-week high—just 4.72% away—further supports the notion of resilience in the current price action.

Such a configuration often attracts technical traders and can provide a foundation for further gains, but it also invites scrutiny on whether the stock is overextended in the near term. The slight underperformance on the latest trading day could be a minor pullback within this broader uptrend — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Performance: Hospital Industry Shows Mixed Results

The hospital sector has delivered a mixed bag of results recently, with some companies posting positive gains while others remain flat or negative. Apollo Hospitals’s outperformance relative to the Sensex and its peers highlights its relative strength within this environment. The sector’s elevated P/E of 69.48 reflects investor confidence in healthcare services, driven by demographic trends and rising healthcare expenditure. Yet, the slight discount in Apollo Hospitals’s valuation may indicate a more cautious stance by investors, possibly due to competitive pressures or regulatory concerns.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold before the reassessment on 11 May 2026. The updated rating reflects a comprehensive four-parameter analysis that factors in valuation, performance, technicals, and sector context. The stock’s strong long-term returns and technical positioning contrast with a valuation slightly below the industry average, creating a nuanced profile that investors must weigh carefully — what is the current rating?

Conclusion: A Balanced Data-Driven View

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock with strong long-term performance, a valuation slightly below its sector average, and a robust technical setup. While short-term momentum shows some moderation, the stock remains well-positioned above all key moving averages and close to its 52-week high. The sector’s mixed results and the stock’s previous Hold rating add further layers to the analysis, making it essential to consider all angles before drawing conclusions — should investors in Apollo Hospitals hold, buy more, or reconsider?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today